Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCENT: Abatacept for GVHD Prevention in Pediatric NMHD Transplant
NCT03924401Phase 2Active, not recruiting
- Sponsor
- Emory University
- Start
- Aug 2019
- Primary completion
- Mar 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in graft-versus-host disease (GVHD), sponsored by Emory University. Started Aug 2019; status: active, not recruiting.
02
Drugs
abatacept
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT03924401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03924401.